FeedingTrends
Acute Respiratory Distress Syndrome (Ards) Treatment Market
a month ago
4 min read

Acute Respiratory Distress Syndrome (Ards) Treatment Market

The global Acute Respiratory Distress Syndrome (ARDS) Treatment market was valued at US$ 388.6 million in 2022 and is projected to reach US$ 476.9 million by 2029, at a CAGR of 3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.

Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-acute-respiratory-distress-syndrome-treatment-forecast-2023-2029-848

This report aims to provide a comprehensive presentation of the global market for Acute Respiratory Distress Syndrome (ARDS) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Respiratory Distress Syndrome (ARDS) Treatment. This report contains market size and forecasts of Acute Respiratory Distress Syndrome (ARDS) Treatment in global, including the following market information:

Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global top five companies in 2022 (%)

North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.

We surveyed the Acute Respiratory Distress Syndrome (ARDS) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)

Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Segment Percentages, by Type, 2022 (%)

  • Oral

  • Intravenous Injection

  • Intramuscular Injection

Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)

Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Segment Percentages, by Application, 2022 (%)

  • Hospital Pharmacy

  • Retail Pharmacy

  • Online Pharmacy

Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)

Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Segment Percentages, By Region and Country, 2022 (%)

  • North America

  • US

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Russia

  • Nordic Countries

  • Benelux

  • Rest of Europe

  • Asia

  • China

  • Japan

  • South Korea

  • Southeast Asia

  • India

  • Rest of Asia

  • South America

  • Brazil

  • Argentina

  • Rest of South America

  • Middle East & Africa

  • Turkey

  • Israel

  • Saudi Arabia

  • UAE

  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Acute Respiratory Distress Syndrome (ARDS) Treatment revenues in global market, 2018-2023 (estimated), ($ millions)

  • Key companies Acute Respiratory Distress Syndrome (ARDS) Treatment revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Gilead Sciences Inc.

  • Terumo Corporation

  • Getinge Ab

  • Livanova Plc

  • Medtronic

  • Alung Technologies, Inc.

  • Armstrong Medical

  • Besmed Health Business Corp.

  • Dragerwerk Ag & Co. Kgaa

  • Eurosets

  • F. Hoffmann-la Roche Ltd.

  • Fisher & Paykel Healthcare Limited

  • Fresenius Se & Co. Kgaa

  • Hamilton Medical

  • Nice Neotech Medical Systems Pvt.ltd.

  • Nipro

  • Pfizer Inc.

  • Resmed

  • Smiths Medical

  • Weinmann Emergency Medical Technology Gmbh+co. Kg

Outline of Major Chapters:

  • Chapter 1: Introduces the definition of Acute Respiratory Distress Syndrome (ARDS) Treatment, market overview.

  • Chapter 2: Global Acute Respiratory Distress Syndrome (ARDS) Treatment market size in revenue.

  • Chapter 3: Detailed analysis of Acute Respiratory Distress Syndrome (ARDS) Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

  • Chapter 6: Sales of Acute Respiratory Distress Syndrome (ARDS) Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

  • Chapter 8: The main points and conclusions of the report.

Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-acute-respiratory-distress-syndrome-treatment-forecast-2023-2029-848

CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170Follow Us On linkedin :-https://www.linkedin.com/company/24-market-reports